PACB
Pacific Biosciences of California
2.30$
+1.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -117.0% | -98.7% | -195.0% | -150.7% | -113.8% | -78.1% | -118.6% | -73.9% | -48.7% | -42.7% | -120.2% | -205.8% | -102.2% | |
| 9.8% | 20.0% | 31.0% | 39.7% | 40.3% | 27.9% | 1,003.4% | 11.5% | 11.4% | 10.4% | 10.9% | 22.0% | 13.6% | |
| 35.4% | 28.4% | 50.3% | 47.8% | 45.7% | 40.9% | 24.8% | 29.9% | 28.6% | 21.5% | 12.0% | 35.2% | 24.3% | |
| -22.6% | -13.3% | -65.3% | -17.6% | -43.2% | 21.3% | -6.4% | -9.7% | 8.3% | 16.8% | 8.5% | -7.2% | 6.9% | |
| 1.5% | 3.5% | 10.0% | 4.1% | 2.0% | 4.1% | 17.2% | 1.4% | 0.2% | 1.9% | 8.2% | 11.8% | 5.4% | |
| 435.1% | -114.1% | -88.0% | 213.4% | 57.7% | 148.5% | 121.8% | 63.6% | 49.2% | 58.3% | 96.5% | 194.7% | 98.4% | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| -1.4% | -139.8% | 16.9% | -0.4% | 2.0% | -128.0% | 5.3% | 0.0% | 3.8% | -7.7% | 3.9% | 4.3% | 0.7% | |
| 316.7% | -352.5% | -266.1% | 63.6% | -53.0% | -57.6% | 8.4% | -10.3% | 4.3% | 15.6% | -20.0% | -6.8% | -0.9% | |
| -118.5% | -102.2% | -205.0% | -154.8% | -111.8% | -82.3% | -135.8% | -75.3% | -48.4% | -44.6% | -128.4% | -217.6% | -107.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.